Lunch & learn with uBriGene at the 9th CAR-TCR summit
uBriGene is pleased to announce our participation in the 9th CAR-TCR Summit, an esteemed event dedicated to advancing cell therapy for...
top of page
- Aug 6
- 2 min
uBriGene congratulates strategic partner InnoVec Biotherapeutics on FDA clearance of IND for IVB103, an AAV-based gene therapy
GERMANTOWN, Md., August 7, 2024 - uBriGene Biosciences (uBriGene) , a global CDMO leader, is excited to announce that its strategic...
- May 28
- 1 min
Join uBriGene Biosciences to discover the future of biotech at BIO San Diego Jun 03 - 06!
Get ready for an electrifying experience at the BIO International Convention — the largest and most comprehensive event for...
- Apr 24
- 2 min
uBriGene's educational webinar series on ATMPs development and manufacturing
Embark on a journey from ATMPs concept to commercialization with uBriGene's groundbreaking webinar series. As leaders in the development...
- Apr 24
- 2 min
uBriGene's showcase at ISCT2024 Vancouver May 29 - Jun 1
We are delighted to announce that uBriGene will exhibit at the International Society for Cell and Gene Therapy (ISCT) 2024 conference. As...
- Apr 17
- 2 min
uBriGene will exhibit at ASGCT2024 this May 7 – 11 in Baltimore
We’re excited to share that uBriGene will be participating in ASGCT2024 with an assortment of engaging activities. We will showcase...
- Mar 14
- 1 min
New service launch - Cell therapy potency analytical development and GMP testing
We at uBriGene Biosciences are excited to launch the new Cell Therapy Potency Analytical Development and GMP Testing service at the...
- Feb 2
- 1 min
Top 3 success factors for cell therapy potency assays
Do you know what FDA is looking for in the cell therapy potency assays? FDA published a guideline in Dec 2023 on CGT potency assay....
- Jul 31, 2023
- 1 min
uBriGene (Boston) Biosciences completed the transaction with Mustang Bio, Inc. (Nasdaq: MBIO)
uBriGene (Boston) Biosciences Inc. (“uBriGene”), the U.S. subsidiary of uBriGene Group, a leading cell and gene therapy contract...
- May 18, 2023
- 3 min
Cell and gene therapy CDMO targets North American growth with major US acquisition
uBriGene Biosciences Inc. (uBrigene), a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into...
bottom of page